Frontiers in Oncology (Dec 2024)

Corrigendum: Bruceine H mediates EGFR-TKI drug persistence in NSCLC by Notch3-dependent β-catenin activating FOXO3a signaling

  • Jiahui Wu,
  • Xiao He,
  • Ziwei Xiong,
  • Lingyu Shi,
  • Daofeng Chen,
  • Yulin Feng,
  • Quan Wen

DOI
https://doi.org/10.3389/fonc.2024.1515205
Journal volume & issue
Vol. 14

Abstract

Read online

No abstracts available.

Keywords